The prognostic role of FIGO stage in patients with vulvar cancer: a systematic review and meta-analysis

References

• Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014;64:9-29
   PubMed Web of Science ®Google Scholar
• Stehman FB, Look KY. Carcinoma of the vulva. Obstet Gynecol 2006;107:719-33
   PubMed Web of Science ®Google Scholar
• Hacker NF, Eifel PJ, van der Velden J. Cancer of the vulva. Int J Gynaecol Obstet 2015;131(Suppl 2):S76-S83
   Google Scholar
• Li J, Cai Y, Ke G, et al. Validation of the new FIGO staging system (2009) for vulvar cancer in the Chinese population. Gynecol Oncol 2015;137:274-9
   PubMed Web of Science ®Google Scholar
• Fons G, Hyde SE, Buist MR, et al. Prognostic value of bilateral positive nodes in squamous cell cancer of the vulva. Int J Gynecol Cancer 2009;19:1276-80
   PubMed Web of Science ®Google Scholar
• Hacker NF. Vulvar cancer. In: Berek JS, Hacker NF, editors. Berek & Hacker’s Gynecologic Oncology, 5th edn. Philadelphia: Williams & Wilkins, 2010:576-92
   Google Scholar
• de Hullu JA, van der Zee AG. Surgery and radiotherapy in vulvar cancer. Crit Rev Oncol Hematol 2006;60:38-58
   PubMed Web of Science ®Google Scholar
• Hauspy J, Beiner M, Harley I, et al. Sentinel lymph node in vulvar cancer. Cancer 2007;110:1015-23
   PubMed Web of Science ®Google Scholar
• Xu LQ, Luo RZ, Sun XM, et al. Prognostic analysis of early-stage squamous cell carcinoma of the vulva. World J Surg Oncol 2013;11:20
   PubMed Web of Science ®Google Scholar
• Woelber L, Mahner S, Voelker K, et al. Clinicopathological prognostic factors and patterns of recurrence in vulvar cancer. Anticancer Res 2009;29:545-52
   PubMed Web of Science ®Google Scholar
• Baiocchi G, Cestari FM, Rocha RM, et al. Does the count after inguinofemoral lymphadenectomy in vulvar cancer correlate with outcome? Eur J Surg Oncol 2013;39:339-43
   PubMed Web of Science ®Google Scholar
• Konidaris S, Bakas P, Gregoriou O, et al. Surgical management of invasive carcinoma of the vulva. A retrospective analysis and review. Eur J Gynaecol Oncol 2011;32:505-8
   PubMed Web of Science ®Google Scholar
• Forner DM, Lampe B. Exenteration in the treatment of stage III/IV vulvar cancer. Gynecol Oncol 2012;124:87-91
   PubMed Web of Science ®Google Scholar
• Sutton AJ, Barton P, Sundar S, et al. Cost-effectiveness of sentinel lymph node biopsy vs inguinofemoral lymphadenectomy in women with vulval cancer. Br J Cancer 2013;109:2533-47
   PubMed Web of Science ®Google Scholar
• Vidal-Sicart S, Puig-Tintore LM, Lejarcegui JA, et al. Validation and application of the sentinel lymph node concept in malignant vulvar tumours. Eur J Nucl Med Mol Imaging 2007;34:384-91
   PubMed Web of Science ®Google Scholar
• Brammen L, Staudenherz A, Polterauer S, et al. Sentinel lymph node detection in vulvar cancer patients: a 20 years analysis. Hell J Nucl Med 2014;17:184-9
   PubMed Web of Science ®Google Scholar
• FIGO Committee on Gynecological Oncology. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynecol Obstet 2009;105:103-4
   PubMed Web of Science ®Google Scholar
• Hacker NF. Revised FIGO staging for carcinoma of the vulva. Int J Gynaecol Obstet 2009;105:105-6
   PubMed Web of Science ®Google Scholar
• Odicino F, Pecorelli S, Zigliani L, Creasman WT. History of the FIGO cancer staging system. Int J Gynaecol Obstet 2008;101:205-10
   PubMed Web of Science ®Google Scholar
• Tabbaa ZM, Gonzalez J, Sznurkowski JJ, et al. Impact of the new FIGO 2009 staging classification for vulvar cancer on prognosis and stage distribution. Gynecol Oncol 2012;127:147-52
   PubMed Web of Science ®Google Scholar
• Tan J, Chetty N, Kondalsamy-Chennakesavan S, et al. Validation of the FIGO 2009 staging system for carcinoma of the vulva. Int J Gynecol Cancer 2012;22:498-502
   PubMed Web of Science ®Google Scholar
• van der Steen S, de Nieuwenhof HP, Massuger L, et al. New FIGO staging system of vulvar cancer indeed provides a better reflection of prognosis. Gynecol Oncol 2010;119:520-5
   PubMed Web of Science ®Google Scholar
• Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 2009;151:W65-94
   PubMed Web of Science ®Google Scholar
• Whiting PF, Rutjes AW, Westwood ME, et al.; QUADAS-2 Group. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011;155:529-36
   PubMed Web of Science ®Google Scholar
• Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med 1997;127:820-6
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539-58
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88
   PubMedGoogle Scholar
• Baiocchi G, Silva Cestari FM, Rocha RM, et al. Prognostic value of the number and laterality of metastatic inguinal lymph nodes in vulvar cancer: revisiting the FIGO staging system. Eur J Surg Oncol 2013;39:780-5
   PubMed Web of Science ®Google Scholar
• Sznurkowski JJ, Milczek T, Emerich J. Prognostic factors and a value of 2009 FIGO staging system in vulvar cancer. Arch Gynecol Obstet 2013;287:1211-18
   PubMed Web of Science ®Google Scholar
• Stankevica J, Macuks R, Baidekalna I, Donina S. Midline involvement as a risk factor for vulvar cancer recurrence. Asian Pac J Cancer Prev 2012;13:5237-40
   PubMedGoogle Scholar
• Sun X, Zhang Y, Sun J, et al. The comparative study of former and latest FIGO staging of vulva cancer. Minerva Chir 2012;67:187-95
   PubMed Web of Science ®Google Scholar
• Woelber L, Eulenburg C, Choschzick M, et al. Prognostic role of lymph node metastases in vulvar cancer and implications for adjuvant treatment. Int J Gynecol Cancer 2012;22:503-8
   PubMed Web of Science ®Google Scholar
• Sharma DN, Rath GK, Kumar S, et al. Treatment outcome of patients with carcinoma of vulva: experience from a tertiary cancer center of India. J Cancer Res Ther 2010;6:503-7
   PubMed Web of Science ®Google Scholar
• Tantipalakorn C, Robertson G, Marsden DE, et al. Outcome and patterns of recurrence for International Federation of Gynecology and Obstetrics (FIGO) stages I and II squamous cell vulvar cancer. Obstet Gynecol 2009;113:895-901
   PubMed Web of Science ®Google Scholar
• Gadducci A, Tana R, Barsotti C, et al. Clinico-pathological and biological prognostic variables in squamous cell carcinoma of the vulva. Crit Rev Oncol Hematol 2012;83:71-83
   PubMed Web of Science ®Google Scholar
• Panici PB, Tomao F, Domenici L, et al. Prognostic role of inguinal lymphadenectomy in vulvar squamous carcinoma: younger and older patients should be equally treated. A prospective study and literature review. Gynecol Oncol 2015;137:373-9
   PubMed Web of Science ®Google Scholar